MYC and multiple sclerosis: In the present study, we developed a superior and promising therapeutic strategy utilizing migratory immune cells to deliver NgR(310)ecto-myc-Fc fusion protein directly to disseminated inflammatory demyelinating lesion sites by transplanting NgR(310)ecto-Fc vector-transduced HSCs into the EAE animal model of multiple sclerosis.